{"id":"https://openalex.org/W4210366603","doi":"https://doi.org/10.1016/j.xphs.2022.01.032","title":"Implementing a Clinical Immunogenicity Strategy using Preclinical Risk Assessment Outputs","display_name":"Implementing a Clinical Immunogenicity Strategy using Preclinical Risk Assessment Outputs","publication_year":2022,"publication_date":"2022-02-02","ids":{"openalex":"https://openalex.org/W4210366603","doi":"https://doi.org/10.1016/j.xphs.2022.01.032","pmid":"https://pubmed.ncbi.nlm.nih.gov/35122828"},"language":"en","primary_location":{"id":"doi:10.1016/j.xphs.2022.01.032","doi":"https://doi.org/10.1016/j.xphs.2022.01.032","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.xphs.2022.01.032","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104667324","display_name":"Vibha Jawa","orcid":"https://orcid.org/0000-0001-7019-729X","observed_orcids":["https://orcid.org/0000-0001-7019-729X","https://orcid.org/0000-0002-6463-4729"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Vibha Jawa","raw_affiliation_strings":["Nonclinical Disposition and Bioanalysis, Bristol-Myers Squibb, Princeton, NJ 08648, USA. Electronic address: vibha.jawa@bms.com","Nonclinical Disposition and Bioanalysis, Bristol-Myers Squibb, Princeton, NJ 08648, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nonclinical Disposition and Bioanalysis, Bristol-Myers Squibb, Princeton, NJ 08648, USA. Electronic address: vibha.jawa@bms.com","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"Nonclinical Disposition and Bioanalysis, Bristol-Myers Squibb, Princeton, NJ 08648, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006610576","display_name":"Jad Maamary","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097073","display_name":"Immunai (United States)","ror":"https://ror.org/00saq8k02","country_code":"US","type":"company","lineage":["https://openalex.org/I4210097073"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jad Maamary","raw_affiliation_strings":["Protein Engineering, Immunai, Inc New York, NY 10016, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protein Engineering, Immunai, Inc New York, NY 10016, USA","institution_ids":["https://openalex.org/I4210097073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113547593","display_name":"Michael D. Swanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Swanson","raw_affiliation_strings":["Bioanalytics, Merck & Co., Inc.,770 Sumneytown Pike, West Point PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioanalytics, Merck & Co., Inc.,770 Sumneytown Pike, West Point PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057258942","display_name":"Shuli Zhang","orcid":"https://orcid.org/0000-0001-8006-1134","observed_orcids":["https://orcid.org/0000-0001-8006-1134"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuli Zhang","raw_affiliation_strings":["Discovery Bioanalysis, Merck and Co, 213 E Grand Ave, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Bioanalysis, Merck and Co, 213 E Grand Ave, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002900779","display_name":"Diana L. Montgomery","orcid":"https://orcid.org/0000-0002-1084-4720","observed_orcids":["https://orcid.org/0000-0002-1084-4720"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana Montgomery","raw_affiliation_strings":["ADME and Discovery Toxicology, Merck & Co., Inc.,770 Sumneytown Pike, West Point PA 19486, USA"],"raw_orcid":"https://orcid.org/0000-0002-1084-4720","affiliations":[{"raw_affiliation_string":"ADME and Discovery Toxicology, Merck & Co., Inc.,770 Sumneytown Pike, West Point PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5104667324"],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":0.3934,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.36888627,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"111","issue":"4","first_page":"960","last_page":"969"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8230000138282776},{"id":"https://openalex.org/keywords/biologics","display_name":"biologics","score":0.9259999990463257},{"id":"https://openalex.org/keywords/risk-reduction","display_name":"risk mitigation","score":0.6449999809265137},{"id":"https://openalex.org/keywords/quality-by-design","display_name":"quality by design","score":0.8240000009536743},{"id":"https://openalex.org/keywords/risk-score","display_name":"risk score","score":0.5339999794960022},{"id":"https://openalex.org/keywords/pharmacogenomics","display_name":"pharmacogenomics","score":0.8050000071525574},{"id":"https://openalex.org/keywords/regulatory-submissions","display_name":"regulatory submissions","score":0.5360000133514404},{"id":"https://openalex.org/keywords/investigational-new-drug-application","display_name":"Investigational New Drug application","score":0.5519999861717224},{"id":"https://openalex.org/keywords/candidate-selection","display_name":"candidate selection","score":0.3700000047683716}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8547552824020386},{"id":"https://openalex.org/C170734499","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenomics","level":2,"score":0.6788598299026489},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.6189135909080505},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.5873383283615112},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5765931606292725},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47412800788879395},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4459119439125061},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4315219521522522},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.4291737675666809},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3714447617530823},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3340598940849304},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3207463026046753},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3008025586605072},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1781485378742218},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16596317291259766},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.12631988525390625},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.xphs.2022.01.032","doi":"https://doi.org/10.1016/j.xphs.2022.01.032","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.xphs.2022.01.032","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:35122828","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35122828","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W90110751","https://openalex.org/W1944657476","https://openalex.org/W1964339501","https://openalex.org/W1966025583","https://openalex.org/W1970089737","https://openalex.org/W1978621527","https://openalex.org/W1983638295","https://openalex.org/W1993511309","https://openalex.org/W2025122282","https://openalex.org/W2029982776","https://openalex.org/W2031362503","https://openalex.org/W2037201482","https://openalex.org/W2044692977","https://openalex.org/W2057254671","https://openalex.org/W2059385530","https://openalex.org/W2064882706","https://openalex.org/W2078172351","https://openalex.org/W2086437884","https://openalex.org/W2092720388","https://openalex.org/W2097527799","https://openalex.org/W2100350770","https://openalex.org/W2113202013","https://openalex.org/W2114964760","https://openalex.org/W2130528924","https://openalex.org/W2132280606","https://openalex.org/W2140035322","https://openalex.org/W2140377154","https://openalex.org/W2149350146","https://openalex.org/W2150178690","https://openalex.org/W2155294390","https://openalex.org/W2166304356","https://openalex.org/W2169844063","https://openalex.org/W2281597363","https://openalex.org/W2481068577","https://openalex.org/W2517194758","https://openalex.org/W2530948814","https://openalex.org/W2551782790","https://openalex.org/W2578864244","https://openalex.org/W2592265634","https://openalex.org/W2596236174","https://openalex.org/W2610188915","https://openalex.org/W2619197807","https://openalex.org/W2670890989","https://openalex.org/W2671261300","https://openalex.org/W2736550573","https://openalex.org/W2753400018","https://openalex.org/W2760974752","https://openalex.org/W2766755664","https://openalex.org/W2782530467","https://openalex.org/W2785439933","https://openalex.org/W2787069637","https://openalex.org/W2807183161","https://openalex.org/W2808509820","https://openalex.org/W2911342550","https://openalex.org/W2946033191","https://openalex.org/W3004413935","https://openalex.org/W3039467801","https://openalex.org/W3113128227","https://openalex.org/W3203725313","https://openalex.org/W3209301640"],"related_works":["https://openalex.org/W7221958196","https://openalex.org/W7214905298","https://openalex.org/W4410604972","https://openalex.org/W2003712657","https://openalex.org/W2783270203","https://openalex.org/W2117790829","https://openalex.org/W3198347800","https://openalex.org/W2090486574","https://openalex.org/W2029859966","https://openalex.org/W2470318958"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-02-08T00:00:00"}